挑战和策略对瘤性病毒疗法对于leptomeningeal转移的挑战和战略
Jia-Li Zhao1, Bi-Lin Lin1, Chen Luo1
1Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1 Minde Road, Nanchang, Jiangxi, China.
Journal of translational medicine
|November 6, 2024
概括
瘤病毒 (OVs) 显示出治疗脑膜转移 (LM),一种严重的癌症并发症的前景. 这篇评论探讨了OV疗法.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 脑膜转移 (LM) 在晚期癌症患者中显著降低了生存率和生活质量.
- 目前尚缺少针对LM的标准化治疗方法.
- 瘤病毒 (OV) 提供选择性癌细胞复制,转基因传递和免疫刺激.
研究的目的:
- 审查关于脑膜转移病毒疗法的现有研究.
- 评估瘤解毒病毒治疗LM的疗效和安全性.
- 评估使用OVs治疗脑膜转移的可行性,并指导脑脊液 (CSF) 注射的未来发展.
主要方法:
- 对研究病毒治疗脑膜转移的研究综合文献综述.
- 从临床前和临床研究中分析报告的疗效和安全性数据.
- 在LM治疗的背景下评估瘤性病毒治疗的潜力.
主要成果:
- 之前的研究表明,OVs在治疗恶性溢出 (多发性和周周) 中具有有前途的治疗效果.
- 该审查综合了关于应用OVs治疗LM的潜在好处和挑战的数据.
- 现有数据表明,开发用于直接注射到脑脊液 (CSF) 的OVs的可行性.
结论:
- 瘤性病毒疗法为治疗脑膜转移提供了潜在的新途径.
- 需要进一步的研究和开发,以优化OV用于CSF输送和LM的临床应用.
- 成功的OV应用可以显著提高LM患者的生存率和生活质量.
相关概念视频
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484